Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki Disease

Recruiting

Phase 2

DoxycyclineDoxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki Disease

Sponsor:

Hawaii Pacific Health

Code:

NCT01917721

Conditions

Kawasaki Disease

Coronary Aneurysm

Eligibility Criteria

Sex: All

Age: 1 - 21

Healthy Volunteers: Not accepted

Interventions

Doxycycline

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-16. This information was provided to ClinicalTrials.gov by Hawaii Pacific Health on 2019-08-28.